These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2013-002112-27||Effect of MD1003 in chronic visual loss related to optic neuritis in multiple sclerosis: a pivotal randomized double masked placebo controlled study||not-yet-due|
|Ongoing||2013-002113-35||Effect of MD1003 in spinal progressive multiple sclerosis: a pivotal randomized double blind placebo controlled study||not-yet-due|
|Completed, but no date||2014-000698-38||MD1003 IN ADRENOMYELONEUROPATHY: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY||bad-data|
|Not reported||2015-005810-31||Effect of MD1003 in amyotrophic lateral sclerosis: a randomized, double blind placebo controlled study||2018-05-24||due-trials|
|Listed as ongoing, but also has a completion date||2016-000700-29||Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled study.||2020-05-05||bad-data|